• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • 2020 in Review

    Global health breakthroughs — other than for COVID-19 — in 2020

    Research and development efforts may have focused on COVID-19 in 2020, but there were still some exciting findings on treatments and diagnostics for other global health challenges this year.

    By Jenny Lei Ravelo // 22 December 2020

    Related Stories

    Can health systems keep pace with HIV prevention’s breakthrough?
    Can health systems keep pace with HIV prevention’s breakthrough?
    Devex CheckUp: More questions than answers for lenacapavir
    Devex CheckUp: More questions than answers for lenacapavir
    The power of diagnostics to improve mental health
    The power of diagnostics to improve mental health
    In Malawi, the fight to get HIV services back on track post-USAID cuts
    In Malawi, the fight to get HIV services back on track post-USAID cuts
    A child receives polio vaccine at a health center in Bishoftu, Ethiopia. Photo by: UNICEF Ethiopia / Mulugeta Ayene / CC BY-NC-ND

    MANILA — The speed in which new coronavirus tests, treatments, and vaccines have been made available this year was unprecedented in history, according to scientists and public health experts.

    While welcome, a focus on these tools has raised concerns among some experts in the global health sector. The pandemic has led to pauses and delays — some indefinite — in clinical trials for tools to address other diseases, as well as a shift in funding and expertise to COVID-19 in both the public and private sectors, according to a new report by the Global Health Technologies Coalition. A lack of reagents and personal protective equipment also had an impact on other research and development efforts, the report found.

    But amid these disruptions were also breakthroughs in new treatments and diagnostics for other global health challenges. Here are just a few:

    Study finds malaria drug can also prevent relapse in children

    The Plasmodium vivax parasite has a feature in which it stays dormant in the liver and, if not eliminated, can cause malaria disease relapse and contribute to its ongoing transmission. A new drug approved for use in adults in a few countries has now shown to be effective in children as well.

    Can this new injectable deliver on its promise to reduce HIV transmission?

    Cabotegravir, an investigative injectable drug for HIV, was found to be 66% more effective than oral preexposure prophylaxis in preventing HIV among men and transgender women. A separate study also found it is 89% more effective than oral PrEP in preventing HIV in women.

    'Optimized for the underserved': A new diagnostic test built for low-income settings

    A new portable diagnostic platform could change the way sickle cell disease is tested and offer a model for developing point-of-care tests for a range of diseases in low-resource settings. Gazelle, the sickle cell disease test launched by medical diagnostic device company Hemex Health, has received regulatory approval in India and Ghana.

    After almost 40 years, there's now a shorter treatment for TB

    A large-scale international study found that a four-month treatment course replacing rifampin and ethambutol with high-dose rifapentine and moxifloxacin, respectively, is as safe and effective as the six-month treatment regimen in curing patients with drug-susceptible tuberculosis.

    First ever vaccine listed under WHO emergency use

    Michel Zaffran reflects on polio lessons and the job ahead

    Before stepping down from his role at the end of 2020, the WHO polio director hopes to oversee the launch of a new oral polio vaccine and help strategize the Global Polio Eradication Initiative. Speaking with Devex, he also shares advice for his successor.

    In November, the World Health Organization’s prequalification program issued interim emergency use listing for the novel oral polio vaccine type 2, which is meant to replace the currently used monovalent type 2 oral polio vaccine and control outbreaks caused by circulating vaccine-derived poliovirus type 2. With the emergency use listing, the vaccine can now be introduced to select countries for initial use. Discussions are ongoing to identify the first countries to utilize the new vaccine.

    • Global Health
    • Research
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Jenny Lei Ravelo

      Jenny Lei Ravelo@JennyLeiRavelo

      Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.

    Search for articles

    Related Stories

    Global healthCan health systems keep pace with HIV prevention’s breakthrough?

    Can health systems keep pace with HIV prevention’s breakthrough?

    Devex CheckUpDevex CheckUp: More questions than answers for lenacapavir

    Devex CheckUp: More questions than answers for lenacapavir

    Accelerating Action: Sponsored by HemoCueThe power of diagnostics to improve mental health

    The power of diagnostics to improve mental health

    Global healthIn Malawi, the fight to get HIV services back on track post-USAID cuts

    In Malawi, the fight to get HIV services back on track post-USAID cuts

    Most Read

    • 1
      Revolutionizing lung cancer care and early screening in LMICs
    • 2
      How local entrepreneurs are closing the NCD care gap in LMICs
    • 3
      Uncertainty ‘new normal’ as World Bank, IMF meet amid aid cuts, discord
    • 4
      Opinion: An industry playbook for addressing NCDs in LMICs
    • 5
      Devex Dish: The World Bank plants a $9 billion-a-year seed
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement